The biology behind scurvy explains why its symptoms can be so dramatic and so deceptive at the same time. Ascorbic acid, or vitamin C, is an essential cofactor for the enzymes that hydroxylate proline and lysine residues in collagen, the structural protein that gives connective tissue its tensile strength. Classic work by Murad and colleagues, published in the Proceedings of the National Academy of Sciences in 1981 and cited in the vignette, demonstrated that ascorbic acid directly regulates collagen synthesis. Without it, fibroblasts produce collagen that cannot be properly cross-linked, and the scaffolding of blood vessels, skin, gums, and wound granulation tissue begins to fail. Later research by Boyera and colleagues confirmed that vitamin C and its derivatives stimulate collagen synthesis and cross-linking in normal human fibroblasts, underlining how central this single micronutrient is to tissue integrity.

That molecular failure produces the textbook picture of scurvy: perifollicular hemorrhages, corkscrew hairs, bleeding gums, poor wound healing, joint pain, and fatigue. But the vignette’s central point is that the disease does not always read from the textbook. When scurvy presents atypically, as it did in this post-bariatric patient, the cutaneous and systemic findings can be subtle, scattered, or mistaken for other dermatologic and hematologic conditions. The authors, who note that the patient consented to the sharing of the case and clinical images, position the report explicitly as a diagnostic challenge, a phrase that captures the core problem: clinicians rarely have scurvy high on their differential in a well-nourished-looking modern patient, and bariatric surgery patients often do not look malnourished at all.

Bariatric surgery creates the perfect physiological conditions for this kind of stealth deficiency. Procedures such as sleeve gastrectomy and Roux-en-Y gastric bypass fundamentally restructure the gastrointestinal tract, altering gastric acid production, intestinal transit, nutrient mixing, and the length and function of absorbing surfaces. A review by Steenackers and colleagues in The Lancet Gastroenterology and Hepatology, also cited in the report, details the extensive adaptations in gastrointestinal physiology after these operations. On top of the anatomical changes, patients frequently experience changes in taste, smell, and appetite after Roux-en-Y gastric bypass, as documented by Graham and colleagues in Obesity Surgery, which can shift dietary patterns away from the fresh fruits and vegetables that supply most dietary vitamin C. Vitamin C is also heat-labile, so diets heavy in cooked or processed foods deliver less of it even when overall intake appears adequate.

The scale of the problem is documented in the wider literature the authors draw upon. A 2024 meta-analysis by Chen and colleagues in Langenbecks Archives of Surgery examined the long-term prevalence of vitamin deficiencies after bariatric surgery, confirming that micronutrient shortfalls persist for years after the operation, not merely in the immediate postoperative period. Guidelines from Mechanick and colleagues, published as the 2019 update of the Clinical Practice Guidelines for the Perioperative Nutrition, Metabolic, and Nonsurgical Support of Patients Undergoing Bariatric Procedures, recommend structured supplementation and monitoring. Yet studies such as that by Donadelli and colleagues in Nutrition have shown that hypovitaminosis occurs even in patients taking daily vitamin supplementation, suggesting that adherence, formulation, and absorption all conspire against simple prevention. Vitamin C, notably, is not always among the micronutrients routinely emphasized in postoperative regimens, which tend to focus on iron, calcium, vitamin D, and B12.

Perhaps the most striking piece of evidence cited in the vignette comes from a 2023 study by Parrott and colleagues in Obesity Surgery, which used machine learning models to predict vitamin C deficiency in patients with metabolic and bariatric surgery. The very existence of such a study signals how significant the problem has become: researchers are now deploying predictive algorithms to identify which surgical patients are silently running low on ascorbic acid. The title of that paper, What We Are Missing, doubles as an indictment of current clinical practice. Deficiency can develop and progress while patients are technically compliant with their prescribed multivitamins, because standard bariatric supplements may not contain sufficient vitamin C to compensate for altered intake and absorption.

Diagnosing scurvy remains stubbornly low-tech in an age of high-tech medicine. Plasma ascorbic acid levels can be measured, but the test is not universally available, results can take time, and clinicians must first think to order it. The diagnosis is often made clinically, on the basis of characteristic skin findings, dietary history, and a rapid response to vitamin C repletion. That dependence on clinical suspicion is precisely what makes atypical presentations dangerous. A rash on the legs of a post-bariatric patient might be attributed to vasculitis, a medication reaction, thrombocytopenia, or any number of more familiar entities before anyone asks the deceptively simple question: what does this person actually eat? The Mount Sinai authors’ framing of the case as a diagnostic challenge reflects this reality, and their vignette is best understood as an educational tool for the internal medicine and primary care audiences of the journal.

The chemistry of vitamin C adds another layer to the story. Beyond its role in collagen maturation, ascorbic acid is a potent biological antioxidant, and Njus and colleagues, writing in Free Radical Biology and Medicine in 2020, have detailed the chemistry underlying those antioxidant properties. Vitamin C also potentiates nitric oxide synthesis in endothelial cells, as Heller and colleagues demonstrated in the Journal of Biological Chemistry, linking the vitamin to vascular tone and endothelial health. Nitric oxide in turn intersects with vascular endothelial growth factor signaling, a relationship explored by Dulak and Józkowicz in Antioxidants and Redox Signaling. These interconnected pathways help explain why severe deficiency produces not just fragile skin but bleeding, poor perfusion, fatigue, and impaired wound repair throughout the body, and why repletion can produce such rapid clinical improvement.

The broader context is a global rise in bariatric and metabolic surgery, driven by the escalating prevalence of obesity and its complications. Each year, hundreds of thousands of patients undergo procedures that permanently alter their nutritional physiology, and they carry those alterations for life. A 2023 review by Gandhi and colleagues in the journal Diseases, titled Scurvy: Rediscovering a Forgotten Disease, catalogued the resurgence of the condition in modern populations, including patients with restricted diets, alcohol use disorder, and malabsorptive surgery. The pattern is consistent: scurvy today is overwhelmingly a disease of medical and social complexity, not of maritime deprivation, and it surfaces in populations that clinicians do not instinctively associate with classical malnutrition.

The takeaway from the Mount Sinai vignette is both humble and actionable. Scurvy is preventable with a few milligrams of vitamin C a day, easily treated with oral repletion, and completely reversible in its early stages, yet it can still evade diagnosis in a modern hospital because nobody thinks of it. For the growing population of bariatric surgery patients, the case argues for vigilance: routine assessment of dietary vitamin C intake, awareness that standard supplements may not suffice, and a low threshold to consider deficiency when unexplained skin findings, bleeding, or musculoskeletal pain appear. For clinicians everywhere, it is a reminder that ancient diseases do not vanish; they adapt. As Mavuri and Kutscher’s report makes clear, the patient with a mysterious rash in the era of metabolic surgery may be carrying a diagnosis that is centuries old, waiting for someone to ask the right question about a piece of fruit.

Subject of Research: Atypical scurvy caused by vitamin C deficiency in a patient after bariatric surgery

Article Title: Atypical Presentation of Scurvy in a Post-Bariatric Surgery Patient: A Diagnostic Challenge

Article References: Mavuri, S., & Kutscher, E. (2026). Atypical Presentation of Scurvy in a Post-Bariatric Surgery Patient: A Diagnostic Challenge. Journal of General Internal Medicine. https://doi.org/10.1007/s11606-026-10870-0

Image Credits: AI Generated

DOI: 10.1007/s11606-026-10870-0

Keywords: scurvy, vitamin C deficiency, bariatric surgery, collagen synthesis, nutritional deficiency, diagnostic challenge, rash, malabsorption, gastric bypass, internal medicine, micronutrients, clinical vignette

The research team, led by Xiaochen Yang and Min Gao of the Nuffield Department of Primary Care Health Sciences, drew on the Clinical Practice Research Datalink Aurum, a vast database of anonymised electronic health records from British general practices. Because almost the entire UK population is registered with a GP, these records offer an unusually complete picture of what happens to patients long after they leave the operating theatre. The researchers identified adults aged 18 or older with severe obesity, defined as a body mass index of 35 kilograms per square metre or higher, who had never previously been diagnosed with depression or anxiety. Crucially, by excluding people with a pre-existing psychiatric history, the study could focus on new-onset, or incident, mental illness rather than the continuation of old conditions.

From this population, the team assembled two carefully matched groups. Between January 2000 and January 2022, 7,814 patients underwent bariatric surgery, whether gastric bypass, sleeve gastrectomy, or adjustable gastric banding. Each surgical patient was matched to five patients with severe obesity who received behavioural weight management, such as structured diet and lifestyle programmes, producing a comparison group of 36,941 people. Matching was performed on age, sex, body mass index, and calendar year, so that the two groups started from broadly similar demographic and clinical positions. In total, 44,755 participants were followed for a median of 4.8 years, with some tracked for as long as 15 years, generating an unusually robust long-term dataset for this kind of question.

The results were striking. Over the follow-up period, 23.1 percent of surgical patients developed depression, compared with 17.4 percent of those in the behavioural weight management group. Anxiety followed a similar pattern, with new diagnoses in 9.0 percent of the surgery group versus 7.1 percent of the comparison group. When the researchers applied multivariable Cox proportional hazards models, statistical tools that estimate the risk of an event over time while adjusting for other factors, surgery was associated with a 36 percent higher hazard of incident depression and a 31 percent higher hazard of incident anxiety. In epidemiological terms, the hazard ratios of 1.36 and 1.31, with confidence intervals that excluded the null value of one, indicate associations that are unlikely to be explained by chance.

The consistency of the signal across subgroups strengthens the finding. The elevated risk of depression appeared regardless of whether patients started with a body mass index of 35 or well above it, and both depression and anxiety risks were raised across all three procedure types, from the restrictive gastric band to the more invasive gastric bypass. The researchers also tested whether the effect differed by age or sex and found no evidence of interaction, meaning the association held for men and women, and for younger and older patients alike. Sensitivity analyses, in which the team varied definitions and model assumptions, left the conclusions intact, suggesting the result is not an artefact of a particular analytical choice.

Why might an operation that so often improves lives also raise the risk of psychiatric illness? The study was observational, so it cannot establish cause and effect, but several biological and psychological mechanisms are plausible. Rapid and substantial weight loss after surgery dramatically alters gut hormone signalling, including changes in ghrelin, GLP-1, and peptide YY, hormones that communicate between the gut and the brain and are increasingly implicated in mood regulation. Nutrient malabsorption, particularly after gastric bypass, can lead to deficiencies in thiamine, vitamin B12, folate, and iron, all of which have documented links to depressive symptoms when left uncorrected. Alcohol absorption also changes after bypass procedures, and disordered drinking is a recognised psychiatric complication in some surgical populations.

Psychological factors may be equally important. Surgery reshapes a person’s relationship with food at extraordinary speed, and patients who relied on eating as a coping strategy can find themselves without that mechanism while still facing the life stressors that contributed to their obesity in the first place. Body image does not always adjust in step with the scales, and some patients report a difficult transition period in which loose skin, changed social dynamics, and unmet expectations take a toll. There is also the possibility of reverse causation in a subtler form: patients who undergo surgery may simply interact with the health system more frequently, increasing the chances that emerging depression or anxiety is detected and recorded, whereas similar symptoms in the behavioural group might go unrecognised in primary care records.

The authors are careful to frame their findings as a call for vigilance rather than a warning against surgery. Bariatric procedures remain among the most effective treatments available for severe obesity and its metabolic complications, and the absolute increase in psychiatric diagnoses, while statistically robust, translates into a modest difference for any individual patient. The practical implication is that mental health should be monitored as systematically as nutritional status in the years after an operation. Structured screening for depression and anxiety at routine follow-up appointments, clear pathways to psychological support, and education for patients and clinicians about early warning signs could all help ensure that problems are caught before they become disabling.

The study also carries a broader message for the field of obesity medicine. As newer pharmacological therapies, including GLP-1 receptor agonists, reshape the treatment landscape, questions about the psychological consequences of dramatic weight loss are no longer confined to the surgical clinic. Weight loss of any kind, achieved by scalpel or by injection, produces profound physiological and emotional change, and the Oxford findings suggest that clinicians should not assume mental wellbeing improves automatically alongside physical health. The research was funded by the National Institute for Health and Care Research through the Oxford Health Biomedical Research Centre and the Oxford and Thames Valley Applied Research Collaboration, and the authors declare no competing interests.

For the hundreds of thousands of people worldwide who undergo bariatric surgery each year, the message is not that the operation is dangerous to the mind, but that recovery is a whole-person process. A procedure that successfully reverses diabetes and extends life expectancy can still leave a patient struggling in ways that never appear on a surgical chart. This study, one of the largest population-based comparisons of its kind, gives clinicians the evidence they need to make psychological follow-up a standard of care rather than an afterthought, and it gives patients permission to raise low mood or anxiety as legitimate medical concerns in the years after their operation, deserving of the same attention as any wound, deficiency, or metabolic change.

Subject of Research: Long-term risk of depression and anxiety after bariatric surgery compared with behavioural weight management

Article Title: Long-term risk of clinical depression and anxiety after bariatric surgery: a population-based matched cohort study

Article References: Yang, X., Dong, X., Jebb, S. A., Aveyard, P., & Gao, M. (2026). Long-term risk of clinical depression and anxiety after bariatric surgery: a population-based matched cohort study. BMC Medicine. https://doi.org/10.1186/s12916-026-04922-9

Image Credits: AI Generated

DOI: 10.1186/s12916-026-04922-9

Keywords: bariatric surgery, depression, anxiety, obesity, mental health, cohort study, CPRD, gastric bypass, weight management, epidemiology, psychiatry, long-term outcomes